<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Anixa Biosciences and Cleveland Clinic Receive FDA Clearance for Clinical Trials of Breast Cancer Vaccine
Image Overlay - Anixa Biosciences and Cleveland Clinic Receive FDA Clearance for Clinical Trials of Breast Cancer Vaccine

Anixa Biosciences and Cleveland Clinic Receive FDA Clearance for Clinical Trials of Breast Cancer Vaccine

Anixa Biosciences and Cleveland Clinic Receive FDA Clearance for Clinical Trials of Breast Cancer Vaccine

Anixa Biosciences announced that the FDA has cleared the Investigational New Drug (IND) application for its breast cancer vaccine. The technology immunizes against the alpha-lactalbumin protein that is expressed in the mammary glands of women during lactation. After lactation, the protein is no longer expressed until a woman develops breast cancer. Researchers anticipate that the vaccine will support the immune system in destroying cancer cells before they have the opportunity to grow into a mature cancer. Yourway is looking forward to seeing the results of further trials and fully supports the fight against cancer.

Back to Index
Media

Upcoming Events

Evolution Summit

September 20-22, 2021
Boston, MA

Media

Articles

Wendy Xia Stands at the Intersection of Science and Heart

Open chat
Come chat with us!
Hello! How can I help you?